17 June 2020: Clinical Research
Comprehensive Decongestive Therapy as a Treatment for Secondary Lymphedema of the Lower Extremity and Quality of Life of Women After Gynecological Cancer Surgery
Lucia Kendrová 1ABCDEFG* , Wioletta Mikuľáková 1ABEG , Katarína Urbanová 1BEF , Štefánia Andraščíková 2CDG , Silvia Žultáková 2EFG , Peter Takáč 3CDE , Yuriy Peresta 1DEFDOI: 10.12659/MSM.924071
Med Sci Monit 2020; 26:e924071
Table 3 Pearson correlation analysis between improvement in QoL domains after CDT and baseline values of reduction LLL, PLL, pain, and age.
| Δ LYMQOL | Age | Pain (VAS) | Reduction of LLL | Reduction of PLL | ||||
|---|---|---|---|---|---|---|---|---|
| r | P | r | P | r | P | r | P | |
| Δ Symptoms | −0.082 | 0.570 | 0.291 | 0.159 | 0.271 | 0.081 | 0.576 | |
| Δ Body age/appearance | 0.087 | 0.546 | 0.167 | 0.247 | 0.114 | 0.433 | 0.125 | 0.387 |
| Δ Function | 0.132 | 0.359 | 0.362 | 0.010 | 0.024 | 0.868 | −0.038 | 0.791 |
| Δ Mood | −0.131 | 0.364 | 0.204 | 0.155 | 0.010 | 0.945 | 0.037 | 0.801 |
| Δ Overall QoL | −0.254 | 0.076 | −0.501 | −0.125 | 0.386 | −0.048 | 0.741 | |
| QoL – quality of life; CDT – complete decongestive therapy; LLL – lower limb lymphedema; VAS – Visual Analogue Scale; LYMQOL – Lymphoedema Quality of Life. | ||||||||